Pharmaleaders TV
You are here:  / Indian News / News Makers / Health Minister Dr. Mansukh Mandaviya – Government focusing on shift from volume to value; strengthen industry academia linkages through Pharma Research Policy

Health Minister Dr. Mansukh Mandaviya – Government focusing on shift from volume to value; strengthen industry academia linkages through Pharma Research Policy

PHD Chamber of Commerce and Industry (PHDCCI) organized the Pharma Med HD conference on 8th July 2022 at PHD House, New Delhi.

Government is putting together an accessible and affordable healthcare ecosystem for the citizens of the country, said Chief Guest Dr. Mansukh Mandaviya, Hon’ble Union Minister for Chemicals & Fertilizers and Health &Family Welfare, Government of India. Healthy citizens make a healthy society which further makes a healthy nation, so it is very crucial to strengthen this sector. Government is coming up with certain initiatives like Pharma research policy to uplift Industry-academia linkages to magnify research in this area which will bring immediate solutions to the problems.

Government has taken some significant steps to bring in ease in doing business. More than 25000 compliance has been reduced so that industry can thrive and do business easily because our main focus is to shift from volume to value. Also stakeholder consultation is one of our top priorities to move forward in this direction because we do not only see “health as commerce but also as service to mankind”.

Dr. Ram Sewak Sharma, Chief Executive Officer,National Health Authority, briefed about some important uses and benefits of schemes and applications made for affordable health care system. He talked about Unified Health Interface which is created for teleconsultation, record management; data sharing and also it will help a person to find a particular doctor or any drug through verified registry of doctors and drugs respectively.

These type of facilities are created to benefit both provider as well as seeker. Also one more progress in this area has been made through ABHA (health id) which can be created under AYUSHMAN BHARAT to build a record of longitudinal health history. 23 crores accounts already been created, added, Dr. Ram Sewak Sharma.

Shri. Pradeep Multani, President, PHDCCI, mentioned that the Healthcare industry in India is projected to reach $372 billion by 2022 comprising of hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. Several factors are driving the growth of the Indian healthcare sector including an aging population, a growing middle class, the rising proportion of lifestyle diseases, an increased emphasis on public-private partnerships as well as accelerated adoption of digital technologies, including telemedicine, besides heightened interest from investors and increased FDI inflows over the last two decades. Taking into account the support provided by the Central Government through various initiatives and incentive schemes and the offerings of State Governments in ease of doing business, it is the time for collaboration to make India self-reliant in healthcare sector.

Mr. Saurabh Sanyal, Secretary General, PHDCCI, presented a formal vote of thanks and in deliberated the session in the session in which he said that as India heads towards its centenary year of independence, it is time to reflect on the past milestones and chart out a roadmap for the future growth of the Indian healthcare sector. Which he said that as India heads towards its centenary year of independence, it is time to reflect on the past's milestones and chart out a roadmap for the future with questions like Can Indian companies build technological resilience to be disruptors rather than being disrupted?

The Event was sponsored by Samsung, ASG Biochem Pvt. Ltd., SNG, AXA Parentals Ltd. BPL Medical Technologies, BioRX, AIMED, FOPE, Indian Healthcare Angels and US India Strategic Foundation and PHDCCI’s Annual Sponsors – Multani Pharmaceuticals Ltd; Star Wire; PG Industry; Uflex Ltd; DLF Ltd; Continental Carriers Pvt Ltd; Belair Travel & Cargo Pvt Ltd; Radico Khaitan Ltd; Jindal Steel & Power; MMG Group; Paramount Communications; Superior Industries Limited; JK Tyre & Industries Ltd; SMC Investments and Advisors Ltd; Crystal Crop Protection Ltd; Sagar Group of Industries; Samsung India Electronics; Comtech Interio; R E Rogers; AYUSH Herbs Private Ltd; Apeejay Stya Group; DCM Shriram; EaseMyTrip; Blossom Kochhar Beauty Products Pvt Ltd; Oswal Greentech; Trident Group; MV Cotspin Ltd; Synergy Environics Ltd; Ajit Industries Pvt Ltd; P S BEDI & Co.; Indian Farmer &Fertilizers Corporation Ltd; Jindal Steel; Hindware Sanitary; Modern Automobiles; Livit Ltd; Central Coalfields Ltd ; Axa Parenterals; Bhagwati Plastic and Pipes Industries; J K Insurance Brokers Ltd; DD Pharmaceutical Ltd.

PHARMALEADERS

Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in the healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry.

Follow us
Contact us

Network 7 Meadia Group

Plot 5, NS Road No. 12, JVPD, Juhu Scheme, Mumbai, Maharashtra 400049. editorial@pharmaleaders.tv